Brisk Walking or $13k Per Year for Weight Loss Drug - We Review Options, Cost, Ozempic & Wecovy
America's Healthcare Advocate · Cary Hall
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Whether you are wanting to lose weight, prevent Type 2 Diabetes or both, you now can consider the class of drugs described as "glucagon-like peptide-1 (GLP-1) agonists" that work by binding to GLP-1 receptors, which in turn results in lower blood sugar levels and A1C levels and are now being prescribed to reduce appetite and help with weight loss. But there is a high financial cost and you may need to stay on the drug for life. In this episode, I will discuss the latest on Ozempic and Wegovy and which is approved by the US Food and Drug Administration to treat diabetes and which to help with weight loss or to lower risk of cardiovascular disease.
Then we contrast these drugs with the latest knowledge about the effectiveness of "Brisk Walking" as I bring you the latest health and well-being news in this Multi-Topic episode! I'm Cary Hall, America's Healthcare Advocate.
Need help or have something to share?